case_images: PMC10832352_01
case_images: Renal ultrasound showing enlarged prostate indenting into the bladder.
case_images: rjad598f1.jpg
case_images: PMC10832352_01_rjad598f1.jpg
case_images: f1
case_images: Initial renal tract ultrasound (Fig. 1) showed enlarged prostate indenting into the bladder base with high post micturition urine residual volume of 185 ml but no hydronephrosis.
case_images: CT KUB showing irregularly enlarged prostate.
case_images: rjad598f2.jpg
case_images: PMC10832352_01_rjad598f2.jpg
case_images: f2
case_images: CT KUB (Fig. 2) showed irregularly enlarged prostate with bilateral hydroureteronephrosis.
case_images: PET FDG scan pre-R-CHOP chemotherapy showing disease activity in the prostate.
case_images: rjad598f3.jpg
case_images: PMC10832352_01_rjad598f3.jpg
case_images: f3
case_images: FDG PET (Fig. 3) showed unusual distribution pattern of lymphoma involving the prostate with bilateral symmetrical renal, early pulmonary, and possibly right thyroid lobe involvement.
case_images: PET FDG scan post R-CHOP chemotherapy showing prostate with complete resolution from the disease.
case_images: rjad598f4.jpg
case_images: PMC10832352_01_rjad598f4.jpg
case_images: f4
case_images: Progress FDG PET scan (Fig. 4) 3 months post R-CHOP chemotherapy showed complete metabolic response with no avid residual lymphoma.